ilmscore | Pharma Sector (Generic Revlimid Revenue Replacement) Predictions
N/A
Accuracy

Recent Predictions

Total: 1
Correct: 0
Incorrect: 0
Pending: 1
Prediction
Author
Predicted at
Status
Video
After generic Revlimid expiry (Jan 2026), companies are predicted to replace 50-100% of their lost revenue through new complex product approvals, but not exceed the original Revlimid contribution.
"some of them might replace 70% of what they lose in rev limit some companies might at best replace 1..."
Apr 24, 2025
Pending